Sort   by:  
 Page size 
UnknownEfficacy and safety of S-flurbiprofen plaster in knee osteoarthritis patients: A 2-week randomized controlled Phase III clinical trial compared to diclofenac gel.
Not available
S-EPMC9303700 | biostudies-literature
ProteomicsMorquio A syndrome: identification of differential patterns of molecular pathway interactions in bone lesions
Mucopolysaccharidosis type IVA (MPS IVA; Morquio A syndrome) is a rare autosomal recessive lysosomal storage disease (LSD) caused by deficiency of a hydrolase enzyme, N-acetylgalactosamine-6-sulfate sulfatase, and characterized clinically by mainly musculoskeletal manifestations. The mechanisms unde...
ORGANISM(S): Mus musculus (Mouse) 
2024-05-24 | PXD042166 | Pride
Morquio a syndrome Rare disease Swath-ms Protein biomarker 
UnknownMucopolysaccharidosis IVA: correlation between genotype, phenotype and keratan sulfate levels.
Not available
S-EPMC3779837 | biostudies-literature
UnknownTuning in to real-time social interactions in macaques.
Not available
S-EPMC10266005 | biostudies-literature
UnknownIntegrase-Deficient Lentiviral Vector as a Platform for Efficient CRISPR/Cas9-Mediated Gene Editing for Mucopolysaccharidosis IVA
Not available
S-EPMC12295186 | biostudies-literature
UnknownDevelopment of Substrate Degradation Enzyme Therapy for Mucopolysaccharidosis IVA Murine Model.
Not available
S-EPMC6747109 | biostudies-literature
ProteomicsNovel phenotypical and biochemical findings in mucolipidosis type II
Mucolipidosis type II (ML II) is a rare lysosomal storage disorder caused by deficiency of the UDP-GlcNAc:N-acetylglucosamine-1-phosphotransferase enzyme, which catalyzes the synthesis of the mannose-6-phosphate (M6P) targeting signal for lysosomal acid hydrolases. This deficiency hinders lysosomal ...
ORGANISM(S): Homo sapiens (Human) 
2025-05-07 | PXD060270 | Pride
Mucolipidosis ii-iii  early findings  biochemistry  biomarkers  proteomic studies  lysosomal diseases. 
UnknownThree-dimensional human mucopolysaccharidosis IVA chondrocyte culture reveals significant impairments in the lysosomal-mitochondrial crosstalk.
Not available
S-EPMC12488992 | biostudies-literature
UnknownCollagen Type II-Targeting Lentiviral Gene Therapy for Mucopolysaccharidosis IVA.
Not available
S-EPMC12839894 | biostudies-literature
UnknownMolecular Mechanism of Induction of Bone Growth by the C-Type Natriuretic Peptide.
Not available
S-EPMC9180634 | biostudies-literature
Sort   by:  
 Page size